Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BridgeBio Pharma Inc (BBIO) vs Reddit Inc (RDDT) Price & Performance

BridgeBio Pharma IncTrade
Reddit IncTrade

Price performance (Past 24H)

Key statistics

BridgeBio Pharma Inc vs Reddit Inc — how do they compare? BridgeBio Pharma Inc trades at $83.63 (market cap $16.36B), while Reddit Inc trades at $152.36 (market cap $30.05B). The key difference: Reddit Inc is the larger of the two by market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Reddit Inc nearer its low. Which is the better fit depends on your goals.

BBIORDDT
Market Cap
$16.36B$30.05B
Sector
HealthMedia
52-Week High
$90.17$270.71
52-Week Low
$47.29$121.84
Enterprise Value
$18.14B$27.28B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

BridgeBio Pharma Inc

BridgeBio Pharma (BBIO) trades at $84.67, up 0.22% today, with a bullish technical signal and strong analyst consensus. Despite missing Q2 2026 EPS estimates with a loss of $0.78 per share, revenue beat expectations as Attruby sales surged 311% year-over-year. The company maintains a high gross margin of 94.44% but reports negative net income and cash flow from operations, reflecting its growth investment phase.

The outlook is optimistic due to multiple late-stage pipeline catalysts, including three potential product launches by mid-2027 and an FDA decision on encaleret by May 2027. Risks include sustained cash burn, high debt of $1.72 billion, and clinical trial execution. The consensus price target of $104.56 implies significant upside if commercial execution succeeds.

Reddit Inc

Reddit (RDDT) trades at $152.50, down 3.91% amid a bearish technical signal despite strong Q2 2026 results showing 61% revenue growth and earnings beats. The stock faces selling pressure despite analyst consensus of $220.25 price target and 64% buy ratings. Recent CEO share sales and search traffic concerns have weighed on sentiment, though fundamentals remain robust with 31.35% net margins and positive cash flow trends.

The outlook remains bifurcated with strong fundamental performance contrasting with technical weakness. Investment opportunity lies in discounted valuation post-selloff and AI monetization potential, while risks include user growth sustainability and competitive pressures in social media landscape. The stock presents a growth-at-reasonable-price case if execution continues.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

Read more on BBIO

About Reddit Inc

Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.

Read more on RDDT